CXCL10 and Alzheimer disease: In AD patients, the serum levels of CXCL10 and the expression levels of CXCL10 in skin lesions were significantly increased in comparison to the levels observed in HCs (Esaki et al., 2016; Brunner et al., 2017; Lang et al., 2021).